Clinical subtypes of depression are associated with specific metabolic parameters and circadian endocrine profiles in women: The power study

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Cizza, Giovanni ^a   Ronsaville, Donna S ^b   Kleitz, Hayley ^b   Eskandari, Farideh ^a   Mistry, Sejal ^a   Torvik, Sara ^a   Sonbolian, Nina ^a   Reynolds, James C ^c   Blackman, Marc R ^d,e   Gold, Philip W ^b   Martinez, Pedro E ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CORTICOTROPIN; GLUCOSE; HYDROCORTISONE; LEPTIN; LIPID; SEROTONIN UPTAKE INHIBITOR; ALENDRONIC ACID; BIOLOGICAL MARKER;

ABDOMINAL FAT; ADULT; AGE DISTRIBUTION; ARTICLE; ATYPICAL DEPRESSION; BODY COMPOSITION; BODY FAT; BONE DENSITY; BONE TURNOVER; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DISEASE CLASSIFICATION; ENDOCRINE FUNCTION; FEMALE; FEMUR NECK; GLUCOSE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MELANCHOLIA; METABOLIC PARAMETERS; PREMENOPAUSE; PROSPECTIVE STUDY; WAIST HIP RATIO; BLOOD; CLINICAL TRIAL; ENDOCRINE SYSTEM; LABORATORY; METABOLISM; MIDDLE AGED; OSTEOPOROSIS; PATHOPHYSIOLOGY; REPRODUCIBILITY;

ADRENOCORTICOTROPIC HORMONE; ADULT; ALENDRONATE; BIOLOGICAL MARKERS; BODY COMPOSITION; BONE DENSITY; CIRCADIAN RHYTHM; DEPRESSIVE DISORDER, MAJOR; ENDOCRINE SYSTEM; FEMALE; HUMANS; HYDROCORTISONE; LABORATORIES; LEPTIN; MIDDLE AGED; OSTEOPOROSIS; PREMENOPAUSE; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84855319444     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028912     Document Type: Article

References (46)

1. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE, (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 617-27.
2. Benazzi F, (1999) Prevalence and clinical features of atypical depression in depressed outpatients: a 467-case study. Psychiatry Res 86: 259-65.
3. McGinn LK, Asnis GM, Rubinson E, (1996) Biological and clinical validation of atypical depression. Psychiatry Res 60: 191-8.
4. Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison WM, et al. (1988) Antidepressant specificity in atypical depression. Arch Gen Psychiatry 45: 129-37.
5. Fountoulakis KN, Iacovides A, Gerasimou G, Fotiou F, Ioannidou C, et al. (2004) The relationship of regional cerebral blood flow with subtypes of major depression. Prog Neuropsychopharmacol Biol Psychiatry 3: 537-46.
6. Quitkin FM, Rabkin JG, Stewart JW, McGrath PJ, Harrison W, et al. (1985) Sleep of atypical depressives. J Affect Disord 8: 61-7.
7. Gold PW, Chrousos GP, (2002) Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatr 7: 254-75.
8. Lemus CZ, Asnis GM, Halbreich U, Harkavy Friedman JM, et al. (1987) Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity. J Affect Disord 12: 219-21.
9. Withall A, Harris LM, Cumming SR, (2010) A longitudinal study of cognitive function in melancholic and non-melancholic subtypes of major depressive disorder. J Affect Disord 123: 150-7.
10. Carragher N, Adamson G, Bunting B, McCann S, (2009) Subtypes of depression in a nationally representative sample. J Affect Disord 113: 88-99.
11. Thase ME, (2009) Atypical depression: useful concept, but it's time to revise the DSM-IV criteria. Neuropsychopharmacology 34: 2633-41.
12. Matza LS, Revicki DA, Davidson JR, Stewart JW, (2003) Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences. Arch Gen Psychiatry 60: 817-26.
13. Marcus SM, Young EA, Kerber KB, Kornstein S, Farabaugh AH, et al. (2005) Gender differences in depression: findings from the STAR*D study. J Affect Disord 87: 141-50.
14. Novick JS, Stewart JW, Wisniewski SR, Cook IA, Manev R, et al. (2005) Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. J Clin Psychiatry 66: 1002-11.
15. Perugi G, Akiskal HS, Lattanzi L, Cecconi D, Mastrocinque, et al. (1998) The high prevalence of "soft" bipolar (II) features in atypical depression. Compr Psychiatry 39: 63-71.
16. Posternak MA, Zimmerman M, (2002) The prevalence of atypical features across mood, anxiety, and personality disorders. Compr Psychiatry 43: 253-62.
17. Asnis GM, McGinn LK, Sanderson WC, (1995) Atypical depression: clinical aspects and noradrenergic function. Am J Psychiatry 152: 31-6.
18. Brown ES, Varghese FP, McEwen BS, (2004) Association of depression with medical illness: does cortisol play a role? Biol Psychiatry 55: 1-9.
19. Cizza G, Ravn P, Chrousos GP, Gold PW, (2001) Depression: a major, unrecognized risk factor for osteoporosis? Trends Endocrinol Metab 12: 198-203.
20. Eskandari F, Martinez PE, Torvik S, Phillips TM, Sternberg EM, et al. (2007) Premenopausal, Osteoporosis Women, Alendronate, Depression (POWER) Study Group. Low bone mass in premenopausal women with depression. Arch Intern Med 167: 2329-36.
21. Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, et al. (2005) Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 90: 2522-30.
22. Pearson S, Schmidt M, Patton G, Dwyer T, Blizzard L, et al. (2010) Depression and insulin resistance: cross-sectional associations in young adults. Diabetes Care 33: 1128-33.
23. Onyike CU, Crum RM, Lee HB, Lyketsos CG, Eaton WW, (2003) Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 158: 1139-47.
24. Cizza G, (2011) Major depressive disorder is a risk factor for low bone mass, central obesity, and other medical conditions. Dialogues Clin Neurosci 13: 73-87.
25. First MB, Gibbon M, Spitzer RL, Williams JBW, (1997) Structured Clinical Interview for DSM-IV Axis I Disorders- Patient Edition (SCID I/P), Version 2.0. Biometrics Research Department.
26. Eskandari F, Mistry S, Martinez PE, Torvik S, Kotila C, et al. (2005) POWER (Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression) Study Group. Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: implications for greater cardiovascular risk. Metabolism 54: 918-24.
27. Pande RL, Perlstein TS, Beckman JA, Creager MA, (2008) Association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004. Circulation 118: 33-41.
28. Agresti A, (2002) Categorical Data Analysis, 2nd ed New York John Wiley & Sons.
29. Lamers F, de Jonge P, Nolen WA, Smit JH, Zitman FG, et al. (2010) Identifying depressive subtypes in a large cohort study: results from the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry 71: 1582-9.
30. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, et al. (2003) Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 12: 3320-5.
31. Mezuk B, Eaton WW, Albrecht S, Golden SH, (2008) Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 12: 2383-90.
32. McIntyre RS, Rasgon NL, Kemp DE, Nguyen HT, Law CW, et al. (2009) Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap. Curr Diab Rep 9: 51-9.
33. Gold PW, Licinio J, Wong ML, Chrousos GP, (1995) Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann N Y Acad Sci 771: 716-29.
34. Anisman H, Ravindran AV, Griffiths J, Merali Z, (1999) Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry 4: 182-8.
35. Stetler C, Miller GE, (2011) Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med 73: 114-26.
36. Young EA, Carlson NE, Brown MB, (2001) Twenty-four-hour ACTH and cortisol pulsatility in depressed women. Neuropsychopharmacology 25: 267-76.
37. Cizza G, Nguyen VT, Eskandari F, Duan Z, Wright EC, et al. (2010) Low 24-hour adiponectin and high nocturnal leptin concentrations in a case-control study of community-dwelling premenopausal women with major depressive disorder: the Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression (POWER) study. J Clin Psychiatry 71: 1079-87.
38. Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, et al. (1999) Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 23: 775-86.
39. Eikelis N, Schlaich M, Aggarwal A, Kaye D, Esler M, (2003) Interactions between leptin and the human sympathetic system. Hypertension 41: 1072-1079.
40. Gold PW, Wong ML, Goldstein DS, Gold HK, Ronsaville DS, et al. (2005) Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci USA 102: 8303-8.
41. Lu XY, (2007) The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol 6: 648-52.
42. Banks WA, (2011) Extrahypothalamic effects of leptin: a therapeutic for depression and dementia? Endocrinology 152: 2539-41.
43. Karapanou O, Papadimitriou A, (2010) Determinants of menarche. Reprod Biol Endocrinol 8: 115.
44. Harlow BL, Cohen LS, Otto MW, Spiegelman D, Cramer DW, (2004) Early life menstrual characteristics and pregnancy experiences among women with and without major depression: the Harvard study of moods and cycles. J Affect Disord 79: 167-76.
45. Cizza G, Primma S, Coyle M, Gourgiotis L, Csako G, (2010) Depression and osteoporosis: a research synthesis with meta-analysis. Horm Metab Res 42: 467-82.
46. Cizza G, Primma S, Csako G, (2009) Depression as a risk factor for osteoporosis. Trends Endocrinol Metab 8: 367-73.